Sagent Pharmaceuticals, Inc. (SGNT) Tops Q2 EPS by 7c; Cuts FY12 Sales Outlook

Go back to Sagent Pharmaceuticals, Inc. (SGNT) Tops Q2 EPS by 7c; Cuts FY12 Sales Outlook